Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms

References

1. 1.↵
   2. Ruan C,
   3. Long H,
   4. Sun H, et al

   . Endovascular coiling vs. surgical clipping for unruptured intracranial aneurysm: a meta-analysis. Br J Neurosurg 2015;29:485–92 doi:10.3109/02688697.2015.1023771 pmid:26037936

   CrossRefPubMed
2. 2.↵
   2. Norback O,
   3. Gál G,
   4. Johansson M, et al

   . The establishment of endovascular aneurysm coiling at a neurovascular unit: report of experience during early years. Neuroradiology 2005;47:144–52 doi:10.1007/s00234-004-1300-5 pmid:15662497

   CrossRefPubMed
3. 3.↵
   2. Rahme RJ,
   3. Zammar SG,
   4. El Ahmadieh TY, et al

   . The role of antiplatelet therapy in aneurysm coiling. Neurol Res 2014;36:383–88 doi:10.1179/1743132814Y.0000000317 pmid:24617939

   CrossRefPubMed
4. 4.↵
   2. Kim B,
   3. Kim K,
   4. Jeon P, et al

   . Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2014;35:1786–92 doi:10.3174/ajnr.A3955 pmid:24831597

   Abstract/FREE Full Text
5. 5.↵
   2. Kang DH,
   3. Kim BM,
   4. Kim DJ, et al

   . MR-DWI-positive lesions and symptomatic ischemic complications after coiling of unruptured intracranial aneurysms. Stroke 2013;44:789–91 doi:10.1161/STROKEAHA.112.669853 pmid:23204052

   Abstract/FREE Full Text
6. 6.↵
   2. Hahnemann ML,
   3. Ringelstein A,
   4. Sandalcioglu IE, et al

   . Silent embolism after stent-assisted coiling of cerebral aneurysms: diffusion-weighted MRI study of 75 cases. J Neurointerv Surg 2014;6:461–65 doi:10.1136/neurintsurg-2013-010820 pmid:23929549

   Abstract/FREE Full Text
7. 7.↵
   2. Cronqvist M,
   3. Wirestam R,
   4. Ramgren B, et al

   . Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome. Neuroradiology 2005;47:855–73 doi:10.1007/s00234-005-1408-2 pmid:16235046

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Soeda A,
   3. Sakai N,
   4. Sakai H, et al

   . Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2003;24:127–32 pmid:12533341

   Abstract/FREE Full Text
9. 9.↵
   2. Oxley TJ,
   3. Dowling RJ,
   4. Mitchell PJ, et al

   . Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Front Neurol 2011;2:83 doi:10.3389/fneur.2011.00083 pmid:22363312

   CrossRefPubMed
10. 10.↵
    2. Hwang G,
    3. Huh W,
    4. Lee JS, et al

    . Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 2015;72:764–72 doi:10.1001/jamaneurol.2015.0654 pmid:26010803

    CrossRefPubMed
11. 11.↵
    2. Kang HS,
    3. Kwon BJ,
    4. Kim JE, et al

    . Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications. AJNR Am J Neuroradiol 2010;31:1206–10 doi:10.3174/ajnr.A2051 pmid:20223886

    Abstract/FREE Full Text
12. 12.↵
    2. Kim BJ,
    3. Kwon JY,
    4. Jung JM, et al

    . Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. J Neurosurg 2014;121:891–98 doi:10.3171/2014.6.JNS132448 pmid:25036195

    CrossRefPubMed
13. 13.↵
    2. Wiebers DO,
    3. Whisnant JP,
    4. Huston J 3rd., et al

    ; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10 doi:10.1016/S0140-6736(03)13860-3 pmid:12867109

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Ernst M,
    3. Yoo AJ,
    4. Kriston L, et al

    . Is visual evaluation of aneurysm coiling a reliable study end point? Systematic review and meta-analysis. Stroke 2015;46:1574–81 doi:10.1161/STROKEAHA.114.008513 pmid:25944331

    Abstract/FREE Full Text
15. 15.↵
    2. Delgado Almandoz JE,
    3. Crandall BM,
    4. Scholz JM, et al

    . Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device. J Neurointerv Surg 2013;5(suppl 3):iii3–10 doi:10.1136/neurintsurg-2012-010582 pmid:23314576

    Abstract/FREE Full Text
16. 16.↵
    2. Maruyama H,
    3. Takeda H,
    4. Dembo T, et al

    . Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 assay. Intern Med 2011;50:695–98 doi:10.2169/internalmedicine.50.4623 pmid:21467700

    CrossRefPubMed
17. 17.↵
    2. Godino C,
    3. Mendolicchio L,
    4. Figini F, et al

    . Comparison of VerifyNow-P2Y12 test and flow cytometry for monitoring individual platelet response to clopidogrel: what is the cut-off value for identifying patients who are low responders to clopidogrel therapy? Thromb J 2009;7:4 doi:10.1186/1477-9560-7-4 pmid:19419580

    CrossRefPubMed
18. 18.↵
    2. Park KW,
    3. Park JJ,
    4. Jeon KH, et al

    . Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans. Cardiovasc Ther 2012;30:5–11 doi:10.1111/j.1755-5922.2010.00249.x pmid:21129165

    CrossRefPubMed
19. 19.↵
    2. Jeon JS,
    3. Sheen SH,
    4. Hwang G, et al

    . Intraarterial tirofiban thrombolysis for thromboembolisms during coil embolization for ruptured intracranial aneurysms. J Cerebrovasc Endovasc Neurosurg 2012;14:5–10 doi:10.7461/jcen.2012.14.1.5 pmid:23210024

    CrossRefPubMed
20. 20.↵
    2. Bendszus M,
    3. Koltzenburg M,
    4. Burger R, et al

    . Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet 1999;354:1594–07 doi:10.1016/S0140-6736(99)07083-X pmid:10560674

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Ozben S,
    3. Ozben B,
    4. Tanrikulu AM, et al

    . Aspirin resistance in patients with acute ischemic stroke. J Neurol 2011;258:1979–86 doi:10.1007/s00415-011-6052-7 pmid:21509427

    CrossRefPubMed
22. 22.↵
    2. Yamada NK,
    3. Cross DT 3rd.,
    4. Pilgram TK, et al

    . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82 doi:10.3174/ajnr.A0641 pmid:17885244

    Abstract/FREE Full Text
23. 23.↵
    2. Lev EI,
    3. Patel RT,
    4. Maresh KJ, et al

    . Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 2006;47:27–33 doi:10.1016/j.jacc.2005.08.058 pmid:16386660

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Saw J,
    3. Densem C,
    4. Walsh S, et al

    . The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy. JACC Cardiovasc Interv 2008;1:654–59 doi:10.1016/j.jcin.2008.08.017 pmid:19463380

    CrossRefPubMed
25. 25.↵
    2. Almekhlafi MA,
    3. Demchuk AM,
    4. Mishra S, et al

    . Malignant emboli on transcranial Doppler during carotid stenting predict postprocedure diffusion-weighted imaging lesions. Stroke 2013;44:1317–22 doi:10.1161/STROKEAHA.111.000659 pmid:23532010

    Abstract/FREE Full Text
26. 26.↵
    2. Hwang G,
    3. Kim JG,
    4. Song KS, et al

    . Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology 2014;273:194–201 doi:10.1148/radiol.14140070 pmid:24918960

    CrossRefPubMed
27. 27.↵
    2. Dion JE,
    3. Gates PC,
    4. Fox AJ, et al

    . Clinical events following neuroangiography: a prospective study. Stroke 1987;18:997–1004 doi:10.1161/01.STR.18.6.997 pmid:3686597

    Abstract/FREE Full Text
28. 28.↵
    2. Mani RL,
    3. Eisenberg RL

    . Complications of catheter cerebral arteriography: analysis of 5,000 procedures, III: assessment of arteries injected, contrast medium used, duration of procedure, and age of patient. AJR Am J Roentgenol 1978;131:871–74 doi:10.2214/ajr.131.5.871 pmid:101047

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Kato K,
    3. Tomura N,
    4. Takahashi S, et al

    . Ischemic lesions related to cerebral angiography: evaluation by diffusion weighted MR imaging. Neuroradiology 2003;45:39–43 pmid:12525953

    PubMedWeb of Science
30. 30.↵
    2. Britt PM,
    3. Heiserman JE,
    4. Snider RM, et al

    . Incidence of postangiographic abnormalities revealed by diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2000;21:55–59 pmid:10669225

    Abstract/FREE Full Text
31. 31.↵
    2. Hähnel S,
    3. Bender J,
    4. Jansen O, et al

    . Clinically silent cerebral embolisms after cerebral catheter angiography [in German]. Rofo 2001;173:300–05 doi:10.1055/s-2001-12465 pmid:11367837

    CrossRefPubMed